Business

Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer

Precipio to expand its reach globallyNEW HAVEN, Conn., April 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO)

articlePrecipio, Inc.April 18, 20193/company/precipio-inc/news/mr-ori-karev-joins-precipio-executive-team-as-chief-strategy-officer
Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer

About this update from Precipio, Inc.

[{"type":"text","content":"Precipio to expand its reach globallyNEW HAVEN, Conn., April 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced today that Mr. Ori Karev has joined the company as its Chief Strategy Officer. Ori was formerly CEO of UnitedHealthcare Global, the International division of United Healthcare, the world's largest health insurance provider. Under Ori's leadership, UnitedHealthcare Global expanded its operations to more than 100 countries, employing more than 1,000 FTEs. Ori was responsible for the establishment and management of partnerships in numerous countries including China, Japan, Korea, England, Portugal, and the Philippines; and oversaw multiple mergers and acquisitions during his tenure there.Ori is a seasoned executive with over 30 years of executive experience in the healthcare, insurance and mobility industries. An attorney by training, Ori executed numerous global M&A transactions earlier in his career working at Ernst & Young, and at a boutique NY law firm.Ori will be responsible for working with Precipio's senior executive team to develop, as well as execute its expansion strategy both domestically and globally. In the coming months, Precipio intends to launch its global initiatives, delivering the highest quality pathology services to clinicians and patients, worldwide.Furthermore, through Ori's vast professional network, Precipio will seek to initiate new relationships with various healthcare organizations worldwide which have been exploring an adoption of some of Precipio's technologies, including: IV-Cell, HemeScreen and ICE-COLD PCR. These efforts are intended to enhance Precipio's existing domestic market penetration activities.Ori will also be working with leading US health payors in order to identify opportunities where Precipio might be able to deliver better outcomes at lower costs, by addressing the inherent costly challenges arising from misdiagnosis, and deploying Precipio's successful and proprietarily developed processes and solutions.\"I am proud to have Ori join our executive team. Ori will add to our leadership team a unique combination of talent, experience, vision and execution capabilities that will take the company to a whole new level,\" said Ilan Danieli, CEO of Precipio. \"In the few weeks we have been working together, we have already plotted new i...

More updates from Precipio, Inc.